
From Setback to Breakthrough: A CEO’s Journey to a First-in-Class Approval with Reenie McCarthy
Episode 5
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Reenie McCarthy, the CEO of Mighty Therapeutics, formerly known as Stealth BioTherapeutics. Reenie shares her path from venture investor to biotech CEO and the years-long effort to develop and secure approval for a first-in-class therapy targeting mitochondrial dysfunction. She discusses the scientific, regulatory, and funding challenges of advancing a novel treatment through clinical development, as well as the critical role of patient advocacy and the lessons learned from setbacks that ultimately helped shape the company's success. The conversation also explores the future of mitochondrial medicine...
Publisher
Clinical Trialblazers
Link
clinical-trialblazers.simplecast.com/episodes/from-setback-to-breakthrough-a-ceos-journey-to-a-first-in-class-approval-with-reenie-mccarthy-9TSdSBMJ
Published
July 7, 2026
Duration
37 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Parexel
Clinical Trialblazers
@clinicaltrialblazers
#ceosjourney #classapproval #reeniemccarthy #lifesciences #medicine
